BCT.TO
Briacell Therapeutics Corp
Price:  
1.65 
CAD
Volume:  
11,100.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCT.TO WACC - Weighted Average Cost of Capital

The WACC of Briacell Therapeutics Corp (BCT.TO) is 8.0%.

The Cost of Equity of Briacell Therapeutics Corp (BCT.TO) is 12.35%.
The Cost of Debt of Briacell Therapeutics Corp (BCT.TO) is 5.00%.

Range Selected
Cost of equity 10.10% - 14.60% 12.35%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.9% - 9.2% 8.0%
WACC

BCT.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.37 1.72
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.10% 14.60%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.9% 9.2%
Selected WACC 8.0%